| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |